gastro-jРоссийский журнал гастроэнтерологии, гепатологии, колопроктологииRussian Journal of Gastroenterology, Hepatology, Coloproctology1382-43762658-6673«Gastro» LLCgastro-j-1303Research ArticleКЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИCLINICAL GUIDELINESРекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению функциональной диспепсииGuidelines of the Russian gastroenterological association on diagnostics and treatment of functional dyspepsiaИвашкинВ. Т.IvashkinV. T.ШептулинА. А.SheptulinA. A.ЛапинаТ. Л.LapinaT. L.КартавенкоИ. М.KartavenkoI. M.КиприанисВ. А.KiprianisV. A.ОхлобыстинаО. З.OkhlobystinaO. Z.НовожиловН. В.NovozhilovN. V.ГБОУ ВПО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздравсоцразвития РоссииРоссияState educational government-financed institution of higher professional education «Sechenov First Moscow state medical university» Ministry of Health and Social Development of RussiaRussian Federation2012260620122238092Copyright © Ивашкин В.Т., Шептулин А.А., Лапина Т.Л., Картавенко И.М., Киприанис В.А., Охлобыстина О.З., Новожилов Н.В., 20122012Ивашкин В.Т., Шептулин А.А., Лапина Т.Л., Картавенко И.М., Киприанис В.А., Охлобыстина О.З., Новожилов Н.В.Ivashkin V.T., Sheptulin A.A., Lapina T.L., Kartavenko I.M., Kiprianis V.A., Okhlobystina O.Z., Novozhilov N.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.gastro-j.ru/jour/article/view/1303
.
.
ReferencesИвашкин В.Т., Шептулин А.А., Трухманов А.С. Эффективность применения ганатона (итоприда гидрохлорида) в лечении больных функциональной диспепсией // Фарматека. – 2009. – № 13. – С. 50–54.Ивашкин В.Т., Шептулин А.А., Трухманов А.С. Эффективность применения ганатона (итоприда гидрохлорида) в лечении больных функциональной диспепсией // Фарматека. – 2009. – № 13. – С. 50–54.Картавенко И.М. Морфофункциональная оценка двенадцатиперстной кишки у лиц с функциональной диспепсией: Автореф. дис. ... канд. мед. наук. – М., 2008. – 23 с.Картавенко И.М. Морфофункциональная оценка двенадцатиперстной кишки у лиц с функциональной диспепсией: Автореф. дис. ... канд. мед. наук. – М., 2008. – 23 с.Охлобыстина О.З. Некоторые особенности патогенеза, клиники, диагностики и лечения синдрома функциональной диспепсии: Автореф. дис. ... канд. мед. наук. – М., 2007. – 24 с.Охлобыстина О.З. Некоторые особенности патогенеза, клиники, диагностики и лечения синдрома функциональной диспепсии: Автореф. дис. ... канд. мед. наук. – М., 2007. – 24 с.Пюрвеева К.В., Лапина Т.Л., Ивашкин В.Л. и др. Значение сывороточных показателей пепсиногена I, пепсиногена II и гастрина-17 в диагностике атрофического гастрита // Рос. журн. гастроэнтерол. гепатол. колопроктол. – 2005. – Т. 15, № 3. – С.48–51.Пюрвеева К.В., Лапина Т.Л., Ивашкин В.Л. и др. Значение сывороточных показателей пепсиногена I, пепсиногена II и гастрина-17 в диагностике атрофического гастрита // Рос. журн. гастроэнтерол. гепатол. колопроктол. – 2005. – Т. 15, № 3. – С.48–51.Allescher H.-D., Böckenhoff A., Knapp G. et al. Treatment of non-ulcer dyspepsia: a meta-analysis of placebo-controlled prospective studies // Scand. J. Gastroenterol. – 2001. – Vol. 36. – P. 934–941.Allescher H.-D., Böckenhoff A., Knapp G. et al. Treatment of non-ulcer dyspepsia: a meta-analysis of placebo-controlled prospective studies // Scand. J. Gastroenterol. – 2001. – Vol. 36. – P. 934–941.Amarapurkar D.N., Rank P. Randomized, double-blind, comparative study to evaluate the efficacy and safety of ganaton (itopride hydrochloride) and mosapride citrate in the management of functional dyspepsia // J. Indian Med. Assoc. – 2004. – Vol. 102. – P. 735–760.Amarapurkar D.N., Rank P. Randomized, double-blind, comparative study to evaluate the efficacy and safety of ganaton (itopride hydrochloride) and mosapride citrate in the management of functional dyspepsia // J. Indian Med. Assoc. – 2004. – Vol. 102. – P. 735–760.Bazolli F. Choice of first line treatments to optimise eradication // H. pylori resistance and management strategies. – World Congress of Gastroenterology. – Montreal, 2005 (oral presentation).Bazolli F. Choice of first line treatments to optimise eradication // H. pylori resistance and management strategies. – World Congress of Gastroenterology. – Montreal, 2005 (oral presentation).Boekema P.J., van Dam E.F., Bots M.L. et al. Associations between use of alcohol, coffee and smoking and functional bowel symptoms in the general dutch population // DDW – New Orleans, 1998. – Abstract A1070.Boekema P.J., van Dam E.F., Bots M.L. et al. Associations between use of alcohol, coffee and smoking and functional bowel symptoms in the general dutch population // DDW – New Orleans, 1998. – Abstract A1070.Buckley M., O′Morain C. Prevalence of Helicobacter pylori in non-ulcer dyspepsia // Aliment. Pharmacol. Ther. – 1995. – Vol. 9. – Suppl. 2. – P. 53–58.Buckley M., O′Morain C. Prevalence of Helicobacter pylori in non-ulcer dyspepsia // Aliment. Pharmacol. Ther. – 1995. – Vol. 9. – Suppl. 2. – P. 53–58.Buonavolonta R., Goccorullo P., Boccia G. et al. Familial aggregation in children affected by functional gastrointestinal disorders // Gut. – 2008. – Vol. 57. – Suppl. II. – P. 3.Buonavolonta R., Goccorullo P., Boccia G. et al. Familial aggregation in children affected by functional gastrointestinal disorders // Gut. – 2008. – Vol. 57. – Suppl. II. – P. 3.Caldarella M.P., Azpiroz F., Malagelada J.-R. Antro-fundic dysfunction in functional dyspepsia // Gastroenterology. – 2003. – Vol. 124. – P. 1202–1229.Caldarella M.P., Azpiroz F., Malagelada J.-R. Antro-fundic dysfunction in functional dyspepsia // Gastroenterology. – 2003. – Vol. 124. – P. 1202–1229.Camilleri M., Hasler W.I., Parkman H.P. et al. Measurement of gastrointestinal motility in the GI laboratory // Gastroenterology. – 1998. – Vol. 115. – P. 747– 762.Camilleri M., Hasler W.I., Parkman H.P. et al. Measurement of gastrointestinal motility in the GI laboratory // Gastroenterology. – 1998. – Vol. 115. – P. 747– 762.Correa P. Human gastric carcinogenesis: a multistep and multifactorial process – First American Cancer Society award lecture on gastric cancer epidemiology and prevention // Cancer Res. – 1992. – Vol. 52. – P. 7635–7640.Correa P. Human gastric carcinogenesis: a multistep and multifactorial process – First American Cancer Society award lecture on gastric cancer epidemiology and prevention // Cancer Res. – 1992. – Vol. 52. – P. 7635–7640.Corsetti M., Tack J. Mechanisms of functional dyspepsia and its relation to IBS // Irritable bowel syndrome. Diagnosis and treatment / Eds. M. Camilleri, M.C. Spiller, W.B. Saunders. – London. – 2002. – P. 117– 126.Corsetti M., Tack J. Mechanisms of functional dyspepsia and its relation to IBS // Irritable bowel syndrome. Diagnosis and treatment / Eds. M. Camilleri, M.C. Spiller, W.B. Saunders. – London. – 2002. – P. 117– 126.El-Omar E., Penman I., Ardill J.E. et al. A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients. – Gut. – 1995. – Vol. 36. – P. 534–538.El-Omar E., Penman I., Ardill J.E. et al. A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients. – Gut. – 1995. – Vol. 36. – P. 534–538.Feinle-Bisset C., Vozzo R., Horowitz M., Talley N.J. Diet, food intake and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia // Am. J. Gastroenterol. – 2003. – Vol. 99. – P. 170–181.Feinle-Bisset C., Vozzo R., Horowitz M., Talley N.J. Diet, food intake and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia // Am. J. Gastroenterol. – 2003. – Vol. 99. – P. 170–181.Ford F.C. Ching E., Moayyedi P. Meta-analysis of diagnostic tests for coeliac disease in dyspepsia // Aliment. Pharmacol. Ther. – 2009. – Vol. 30. – P. 28–36.Ford F.C. Ching E., Moayyedi P. Meta-analysis of diagnostic tests for coeliac disease in dyspepsia // Aliment. Pharmacol. Ther. – 2009. – Vol. 30. – P. 28–36.Führer M., Vogelsang M., Hammer J. A double blind, placebo controlled study of the oral capsaicin test in patients with functional dyspepsia // Gut. – 2008. – Vol. 57. – Suppl. II. – P. 38.Führer M., Vogelsang M., Hammer J. A double blind, placebo controlled study of the oral capsaicin test in patients with functional dyspepsia // Gut. – 2008. – Vol. 57. – Suppl. II. – P. 38.Holtmann G. Understanding functional dyspepsia & its treatment with itopride // Medical Tribune. – 2006. – 1–15 Nov.Holtmann G. Understanding functional dyspepsia & its treatment with itopride // Medical Tribune. – 2006. – 1–15 Nov.Holtmann G., Talley N.J. Hypothesis driven research and molecular mechanisms in functional dyspepsia: the beginning of a beautiful cooperation in research and practice? // Am. J. Gastroenterol. – 2006. – Vol. 101. – P. 593– 595.Holtmann G., Talley N.J. Hypothesis driven research and molecular mechanisms in functional dyspepsia: the beginning of a beautiful cooperation in research and practice? // Am. J. Gastroenterol. – 2006. – Vol. 101. – P. 593– 595.Holtmann G., Talley N.J. Clinician′s manual on managing dyspepsia. – Life Science Communications. – London, 2000. – 88 p.Holtmann G., Talley N.J. Clinician′s manual on managing dyspepsia. – Life Science Communications. – London, 2000. – 88 p.Holtmann G., Talley N.J., T.Liebregts et al. A placebocontrolled trial of itopride in functional dyspepsia // N. Engl. J. Med. –2006. – Vol. 354. – P. 832–840.Holtmann G., Talley N.J., T.Liebregts et al. A placebocontrolled trial of itopride in functional dyspepsia // N. Engl. J. Med. –2006. – Vol. 354. – P. 832–840.Jackson J.L., O′Malley P.G., Tomkins G. et al. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis // Am. J. Med. – 2000. – Vol. 108. – P. 65–72.Jackson J.L., O′Malley P.G., Tomkins G. et al. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis // Am. J. Med. – 2000. – Vol. 108. – P. 65–72.Jones M.P., Ebert Ch.C. Bloating and somatosensory amplification in functional dyspepsia (FD) // Am. J. Gastroenterol. – 2003. – Vol. 98. – P. 63–64.Jones M.P., Ebert Ch.C. Bloating and somatosensory amplification in functional dyspepsia (FD) // Am. J. Gastroenterol. – 2003. – Vol. 98. – P. 63–64.Kadota K., Takeshima F., Yoda A. et al. Effect of smoking cessation on gastric emptying in smokers // Gut. –2008. – Vol. 57. – Suppl. II. – P. 2.Kadota K., Takeshima F., Yoda A. et al. Effect of smoking cessation on gastric emptying in smokers // Gut. –2008. – Vol. 57. – Suppl. II. – P. 2.Kanath S. Comparative evaluation of the efficacy and tolerability of itopride and metaclopramide in patients with non-ulcer dyspepsia // JAMA-India. – 2003. – Vol. 2. – P. 95–98.Kanath S. Comparative evaluation of the efficacy and tolerability of itopride and metaclopramide in patients with non-ulcer dyspepsia // JAMA-India. – 2003. – Vol. 2. – P. 95–98.Keohane J., Quigley E.M.M. Functional dyspepsia: The role of visceral hypersensitivity in its pathogenesis // World J. Gastoenterol. – 2006. – Vol. 12. – P. 2672–2676.Keohane J., Quigley E.M.M. Functional dyspepsia: The role of visceral hypersensitivity in its pathogenesis // World J. Gastoenterol. – 2006. – Vol. 12. – P. 2672–2676.Knill-Jones R.P. Geographical differences in the prevalence of dyspepsia // Scand. J. Gastroenterol. – 1991– Vol. 26. – Suppl. 182. – P. 17–24.Knill-Jones R.P. Geographical differences in the prevalence of dyspepsia // Scand. J. Gastroenterol. – 1991– Vol. 26. – Suppl. 182. – P. 17–24.Koloski N.A., Talleу N.J., Boyce Ph.M. Epidemiology and health care seeking in the functional GI disorders: a population-based study // Am. J. Gastroenterol. – 2002. – Vol. 97. – P. 2290–2299.Koloski N.A., Talleу N.J., Boyce Ph.M. Epidemiology and health care seeking in the functional GI disorders: a population-based study // Am. J. Gastroenterol. – 2002. – Vol. 97. – P. 2290–2299.Lapidus L., Andersson S., Bengtsson G., Kilander A. Prognosis of dyspepsia in women – a 24-year follow-up of a population sample // Gut. – 2002. – Vol. 34. – Suppl. II. – P. 106.Lapidus L., Andersson S., Bengtsson G., Kilander A. Prognosis of dyspepsia in women – a 24-year follow-up of a population sample // Gut. – 2002. – Vol. 34. – Suppl. II. – P. 106.Lin Z., Eaker E.Y., Sarosiek I., McCallum R. Gastric myoelectrical activity and gastric emptying in patients with functional dyspepsia // Am. J. Gastoenterol. – 1999. – Vol. 94. – P. 2384–2389.Lin Z., Eaker E.Y., Sarosiek I., McCallum R. Gastric myoelectrical activity and gastric emptying in patients with functional dyspepsia // Am. J. Gastoenterol. – 1999. – Vol. 94. – P. 2384–2389.Locke G.R., Weaver A.L., Melton L.J., Talley N.J. Phsychological factors are linked to functional gastrointestinal disorders: a population based nasted case-control study. – Am. J. Gastroenterol. – 2004. – Vol. 99. – P. 350–357.Locke G.R., Weaver A.L., Melton L.J., Talley N.J. Phsychological factors are linked to functional gastrointestinal disorders: a population based nasted case-control study. – Am. J. Gastroenterol. – 2004. – Vol. 99. – P. 350–357.McQuaid K.R. Dyspepsia // Sleisenger and Fordtran′s gastrointestinal and liver disease / Ed. M. Feldman et al., 7th ed. – Philadelphia–London–Toronto–Montreal– Sydney–Tokyo, 2002. – P. 102–118.McQuaid K.R. Dyspepsia // Sleisenger and Fordtran′s gastrointestinal and liver disease / Ed. M. Feldman et al., 7th ed. – Philadelphia–London–Toronto–Montreal– Sydney–Tokyo, 2002. – P. 102–118.Moayyedi P., Deeks J., Talley N.J. et al. An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepance between systematic reviews // Am. J. Gastroenterol. – 2003. – Vol. 98. – P. 2621–2626.Moayyedi P., Deeks J., Talley N.J. et al. An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepance between systematic reviews // Am. J. Gastroenterol. – 2003. – Vol. 98. – P. 2621–2626.Moayyedi P., Delaney B.C., Vakil N. The efficacy of proton pump inhibitors in non-ulcer dyspepsia: a systematic review and economic analysis // Gastroenterology. – 2004. – Vol. 127. – P. 1329–1337.Moayyedi P., Delaney B.C., Vakil N. The efficacy of proton pump inhibitors in non-ulcer dyspepsia: a systematic review and economic analysis // Gastroenterology. – 2004. – Vol. 127. – P. 1329–1337.Moayyedi P., Soo S., Deeks J. et al. Systemic review: Antacids, H2-receptor antagonists, prokinetiks, bismuth and sucralfate therapy for non-ulcer dyspepsia // Aliment. Pharmacol. Ther. – 2003. – Vol. 17. – P. 1215–1227.Moayyedi P., Soo S., Deeks J. et al. Systemic review: Antacids, H2-receptor antagonists, prokinetiks, bismuth and sucralfate therapy for non-ulcer dyspepsia // Aliment. Pharmacol. Ther. – 2003. – Vol. 17. – P. 1215–1227.Mönkemüller K., Malfertheiner P. Drug treatment of functional dyspepsia // World J. Gastroenterol. – 2006. – Vol. 12. – P. 2694–2700.Mönkemüller K., Malfertheiner P. Drug treatment of functional dyspepsia // World J. Gastroenterol. – 2006. – Vol. 12. – P. 2694–2700.Müller-Lissner S., Koelz H.R. Dyspepsiefibel. – Berlin– Heidelberg–New York. – 1991. – 67 s.Müller-Lissner S., Koelz H.R. Dyspepsiefibel. – Berlin– Heidelberg–New York. – 1991. – 67 s.Nimmuan C., Rabe-Hesketh S., Wessely S., Hotopf M. How many functional somatic syndromes? // J. Phychosom. Res. – 2001. – Vol. 51. – P. 549–557.Nimmuan C., Rabe-Hesketh S., Wessely S., Hotopf M. How many functional somatic syndromes? // J. Phychosom. Res. – 2001. – Vol. 51. – P. 549–557.Nyren O., Adami H.-O, Gustavsson S. et al. Social economic effects of non-ulcer dyspepsia // Scand. J. Gastroenterol. – 1985. – Vol. 20. – Suppl. 109. – P. 41–45.Nyren O., Adami H.-O, Gustavsson S. et al. Social economic effects of non-ulcer dyspepsia // Scand. J. Gastroenterol. – 1985. – Vol. 20. – Suppl. 109. – P. 41–45.O′Morain C. Indications for Helicobacter pylori infection erdication // Maastricht-3 Guidelines for Helicobacter pylori infection. – 13. United European Gastroenterology Week. – Copenhagen, 2005 (oral presentation).O′Morain C. Indications for Helicobacter pylori infection erdication // Maastricht-3 Guidelines for Helicobacter pylori infection. – 13. United European Gastroenterology Week. – Copenhagen, 2005 (oral presentation).Peura D. Meeting expectations in FD: clinical and regulatory objectives. Clinician′s viewpoint // Functional dyspepsia: current evidence and cutting edge outcomes. – Abstract book. – Montreal, 2005. – P. 16–18.Peura D. Meeting expectations in FD: clinical and regulatory objectives. Clinician′s viewpoint // Functional dyspepsia: current evidence and cutting edge outcomes. – Abstract book. – Montreal, 2005. – P. 16–18.Samson M., Verhagen M.A., van BergeHenegouwen G.P. et al. Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients // Gastroenterology. – 1999. – Vol. 116. – P. 515–520.Samson M., Verhagen M.A., van BergeHenegouwen G.P. et al. Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients // Gastroenterology. – 1999. – Vol. 116. – P. 515–520.Sarnelli G., Caenepeel Ph., Geypens B. et al. Symptoms associated with impared gastric emptying of solids and liquids in functional dyspepsia // Am. J. Gastroenterol. – 2003. – Vol. 98. – P. 783–788.Sarnelli G., Caenepeel Ph., Geypens B. et al. Symptoms associated with impared gastric emptying of solids and liquids in functional dyspepsia // Am. J. Gastroenterol. – 2003. – Vol. 98. – P. 783–788.Sarnelli G., De Giorgi F., Atteo E. et al. Frequency, symptom evolution and pathophysiological correlates in prospectively identified patients with postinfectious dyspepsia // DDW – New Orleans, 2010. – Abstract M2010.Sarnelli G., De Giorgi F., Atteo E. et al. Frequency, symptom evolution and pathophysiological correlates in prospectively identified patients with postinfectious dyspepsia // DDW – New Orleans, 2010. – Abstract M2010.Sawant P., Das H.S., Desai N. et al. Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia // JAPI. – 2004. – Vol. 52. – P. 626–628.Sawant P., Das H.S., Desai N. et al. Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia // JAPI. – 2004. – Vol. 52. – P. 626–628.Soo Sh., Forman D., Delaney C., Moayyedi P. A systemic review of psychological therapies for nonulcer duspepsia // Am. J. Gastroenterol. – 2004. – Vol. 99. – P. 1817–1822.Soo Sh., Forman D., Delaney C., Moayyedi P. A systemic review of psychological therapies for nonulcer duspepsia // Am. J. Gastroenterol. – 2004. – Vol. 99. – P. 1817–1822.Stanghellini V., Tosetti C., Paternico A. et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia // Gastroenterology. – 1996. – Vol. 110. – P. 1036–1042.Stanghellini V., Tosetti C., Paternico A. et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia // Gastroenterology. – 1996. – Vol. 110. – P. 1036–1042.Tack J. New therapeutic targets for FD: what, how and whom? // Functional dyspepsia: current evidence and cutting edge outcomes . – Abstract book. – Montreal, 2005. – P. 22–24.Tack J. New therapeutic targets for FD: what, how and whom? // Functional dyspepsia: current evidence and cutting edge outcomes . – Abstract book. – Montreal, 2005. – P. 22–24.Tack J., Caenepeel P., Fischler B. et al. Symptoms associated with hypersensitivity to gastric distension in functional dyspepsia // Gastroenterology. – 2001. – Vol. 121. – P. 526–535Tack J., Caenepeel P., Fischler B. et al. Symptoms associated with hypersensitivity to gastric distension in functional dyspepsia // Gastroenterology. – 2001. – Vol. 121. – P. 526–535Tack J., Piessevaux H., Coulie B. et al. Role of impaired gastric accommodation to a meal in functional dyspepsia // Gastroenterology. – 1998. – Vol. 115. – P. 1346– 1352.Tack J., Piessevaux H., Coulie B. et al. Role of impaired gastric accommodation to a meal in functional dyspepsia // Gastroenterology. – 1998. – Vol. 115. – P. 1346– 1352.Tack J., Talley N.J., Camilleri M. et al. Functional gastroduodenal disorders // Gastroenterology. – 2006.– Vol. 130. – P. 1466–1479.Tack J., Talley N.J., Camilleri M. et al. Functional gastroduodenal disorders // Gastroenterology. – 2006.– Vol. 130. – P. 1466–1479.Talley N.J. and the working team for functional gastroduodenal disorders. Functional gastroduodenal disorders // The functional gastrointestinal disorders. – Boston – New York–Toronto–London, 1994. – P. 71–113.Talley N.J. and the working team for functional gastroduodenal disorders. Functional gastroduodenal disorders // The functional gastrointestinal disorders. – Boston – New York–Toronto–London, 1994. – P. 71–113.Talley N.J., Helgeson S.L., Zinsmeister A.R. et al. Gastrointestinal tract symptoms and self-reported abuse: a population-based-study // Gastroenterology. – 1994. – Vol. 107. – P. 1040–1049.Talley N.J., Helgeson S.L., Zinsmeister A.R. et al. Gastrointestinal tract symptoms and self-reported abuse: a population-based-study // Gastroenterology. – 1994. – Vol. 107. – P. 1040–1049.Talley N.J., Janssens L., Lauritsen K. et al. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 month follow up // Br. Med. J. – 1999. – Vol. 318. – P. 833–837.Talley N.J., Janssens L., Lauritsen K. et al. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 month follow up // Br. Med. J. – 1999. – Vol. 318. – P. 833–837.Talley N.J., Meineche-Schmidt V., Pare P. et al. Eficacy of omeprazole im functional dyspepsia: doubleblind, randomized, placebo-controlled trials (the Bond and Opera studies) // Aliment. Pharnacol. Ther. – 1998. – Vol. 12. – P. 1055–1065.Talley N.J., Meineche-Schmidt V., Pare P. et al. Eficacy of omeprazole im functional dyspepsia: doubleblind, randomized, placebo-controlled trials (the Bond and Opera studies) // Aliment. Pharnacol. Ther. – 1998. – Vol. 12. – P. 1055–1065.Talley N.J., Stanghellini V., Heading R.C. et al. Functional gastroduodenal disorders // Rome II. The Functional Gastrointestinal Disorders / Ed. D.A. Drossman, 2th Ed. – Allen Press. – 2000. – P. 299–350.Talley N.J., Stanghellini V., Heading R.C. et al. Functional gastroduodenal disorders // Rome II. The Functional Gastrointestinal Disorders / Ed. D.A. Drossman, 2th Ed. – Allen Press. – 2000. – P. 299–350.Tominaga K., Suzuki H., Umegaki E. et al. Rabeprazole imprоves the symptoms of functional dyspepsia – a double-blind randomized placebo-controlled multi-center trial in Japan: The CAESAR study // DDW – New Orleans, 2010. – Abstract 383.Tominaga K., Suzuki H., Umegaki E. et al. Rabeprazole imprоves the symptoms of functional dyspepsia – a double-blind randomized placebo-controlled multi-center trial in Japan: The CAESAR study // DDW – New Orleans, 2010. – Abstract 383.Van Lelyveld N., Scheffer R., Mundt M., Samson M. Partial gastric volumes and upper abdominal sensations in functional dyspeptic and GERD patients: a 3D ultrasonographic study // Am. J. Gastroenterol. – 2006. – Vol. 101. – P. 1845–1852.Van Lelyveld N., Scheffer R., Mundt M., Samson M. Partial gastric volumes and upper abdominal sensations in functional dyspeptic and GERD patients: a 3D ultrasonographic study // Am. J. Gastroenterol. – 2006. – Vol. 101. – P. 1845–1852.Warrwewijk C.J., van Oijen M.G.H., Paloheimo L.I. et al. Influence of gastric mucosal status on successs of stepwise acid suppressive therapy for dyspepsia // Aliment. Pharmacol. Ther. – 2009. – Vol. 30. – P. 82–89.Warrwewijk C.J., van Oijen M.G.H., Paloheimo L.I. et al. Influence of gastric mucosal status on successs of stepwise acid suppressive therapy for dyspepsia // Aliment. Pharmacol. Ther. – 2009. – Vol. 30. – P. 82–89.Wilhelmsen I., Haug T., Sipponen P., Berstad A. Helicobacter pylori in functional dyspepsia // Scand. J. Gastroenterol. – 1994. – Vol. 29. – P. 522–527.Wilhelmsen I., Haug T., Sipponen P., Berstad A. Helicobacter pylori in functional dyspepsia // Scand. J. Gastroenterol. – 1994. – Vol. 29. – P. 522–527.
The authors declare that there are no conflicts of interest present.